Web-based HIV Prevention Toolkit for HIV
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital tool called "Para ti, para mi, para nosotros (P3)," designed to help male couples prevent HIV and other sexually transmitted infections (STIs). The goal is to assess how effectively this tool encourages couples to adopt proven prevention strategies and create a personalized prevention plan. Participants will either use the tool for six months or join a waitlist to use it later. It suits cisgender male couples who have been in a committed relationship for over three months, live in the Lima metro area, and are open to undergoing HIV and STI testing. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance prevention strategies for male couples.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this web-based HIV prevention toolkit is safe?
Research shows that Para ti, para mi, para nosotros (P3), a digital tool designed to help male couples prevent HIV, is safe to use. An earlier study tested this tool's effectiveness in helping couples follow their prevention plans. The study found no major safety issues. Participants expressed satisfaction with the process and encountered no serious problems, indicating that P3 is user-friendly. The goal is to enhance HIV prevention for couples, and the safety results so far are encouraging.12345
Why are researchers excited about this trial?
Researchers are excited about the P3 web-based HIV prevention toolkit because it offers a new, accessible way to support HIV prevention efforts. Unlike traditional methods that often require in-person visits or ongoing medication, P3 provides a flexible, digital platform that users can access anytime. This toolkit includes interactive modules and resources designed to engage users in meaningful prevention strategies. The convenience and privacy of a web app make it an appealing option for those who may face barriers to accessing traditional HIV prevention services.
What evidence suggests that this trial's treatments could be effective for HIV prevention?
Research has shown that the Para ti, para mi, para nosotros (P3) web app is a promising tool for preventing HIV among cisgender male couples. In earlier studies, 90% of couples found the app very helpful, particularly the activity that aids in making agreements. This indicates that couples are comfortable using the app. In this trial, participants in the intervention arm will access the P3 web app and all its contents for six months. Meanwhile, those in the waitlist control arm will initially have limited access, gaining full access after three months. Another study, the Positive Health Check, demonstrated that the app helps people use proven prevention methods. These findings suggest that P3 could effectively assist couples in creating and following a personalized HIV prevention plan.12367
Who Is on the Research Team?
Jason W Mitchell, PhD
Principal Investigator
Florida International University
Are You a Good Fit for This Trial?
This trial is for cisgender male couples in Lima, Peru who have been in a relationship for over 3 months and are at least 18 years old. They must have had anal sex recently, not experienced partner violence, be willing to test for HIV/STIs, and own a web-connected device.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention arm have access to the P3 web app intervention and all of its contents for 6 months
Waitlist Control
Participants in the waitlist control condition have access to the P3 web app for post-baseline assessment of 3 months, then full access from 3 to 6 months
Follow-up
Participants are monitored for changes in adherence, communication, and HIV/STI incidence
What Are the Treatments Tested in This Trial?
Interventions
- Para ti, para mi, para nosotros (P3)
- Waitlist Control Para ti, para mi, para nosotros (P3)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida International University
Lead Sponsor
University of Southern California
Collaborator
Universidad Peruana Cayetano Heredia
Collaborator